FDA Grants Marketing Clearance to Icare HOME Tonometer

March 23, 2017

Revenio Group's subsidiary, Icare Finland Oy has received FDA marketing approval for the Icare HOME tonometer.

The device is intended to assist clinicians and patients to monitor glaucoma. Continuous monitoring of fluid pressure inside the eye forms a key part of the treatment to prevent progression of the disease and to determine the proper medication.

The Icare HOME tonometer has been granted sales permits in the EU and in 7 other countries. — Cynthia Jessup

View today's stories